FLT3-IN-1 Succinate

1702864-11-6 Basic information More..

Product Name:	FLT3-IN-1 Succinate
Synonyms:	FLT3-IN-1 Succinate;FF 10101 succinate,FF10101 succinate;(S,E)-N-(1-((5-(2-((4-Cyanophenyl)amino)-4-(propylamino)pyrimidin-5-yl)pent-4-yn-1-yl)amino)-1-oxopropan-2-yl)-4-(dimethylamino)-N-methylbut-2-enamide succinate(1:x)
CAS:	1702864-11-6
MF:	C33H44N8O6
MW:	648.77
EINECS:
Mol File:	1702864-11-6.mol

FLT3-IN-1 Succinate manufacturers

Information Error Report

Your Email:

Browse by province 1702864-11-6 Suppliers

Shanghai(2)

Member(2)

All(2)

1702864-11-6 Recommend Suppliers

Recommend You Select Member Companies...

Company Name:	Bide Pharmatech Ltd. Recommend Complaint

Tel:	400-1647117
FAX:
Email:	product02@bidepharm.com
Products Intro:	Product Name:(S,E)-N-(1-((5-(2-((4-Cyanophenyl)amino)-4-(propylamino)pyrimidin-5-yl)pent-4-yn-1-yl)amino)-1-oxopropan-2-yl)-4-(dimethylamino)-N-methylbut-2-enamide succinate(1:x) CAS:1702864-11-6 Purity:98% Package:1mg;5mg;10mg;25mg;50mg Remarks:BD00788711 More...
CB Index:	58
WebSite:	https://www.bidepharm.com/
Related Information:	Sales Network Catalog(62320) User Evaluation

Company Name:	TargetMol Chemicals Inc. Recommend Complaint

Tel:
FAX:
Email:	marketing@tsbiochem.com
Products Intro:	Product Name:FF-10101 succinate CAS:1702864-11-6 Package:25mg/RMB 5470;100mg/RMB 11614;50mg/RMB 7116 More...
CB Index:	58
WebSite:	https://www.targetmol.cn/
Related Information:	Sales Network Catalog(24961) User Evaluation

Tag: 1702864-11-6

HomePage | About Us | Member Companies | Advertising | Contact us | Previous WebSite | MSDS | CAS Index | CAS DataBase | Privacy | Terms
All products displayed on this website are only for non-medical purposes such as industrial applications or scientific research, and cannot be used for clinical diagnosis or treatment of humans or animals. They are not medicinal or edible.
According to relevant laws and regulations and the regulations of this website, units or individuals who purchase hazardous materials should obtain valid qualifications and qualification conditions.